Botanical species · safety record

Sciodaphyllum reticulatum

The EFSA Compendium of Botanicals holds 2 constituent measurements and 3 adverse-effect records for Sciodaphyllum reticulatum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Sciodaphyllum reticulatum (Gleason) Lowry, G.M.Plunkett & M.M.Mora

2Constituent measurements

3Safety records

3Cited sources

0Licensed products (Canada)

Also recorded as

Schefflera sessiliflora Frodin

Synonyms are carried from the source compendium. A species may be traded and studied under more than one name, which is exactly how a safety record gets lost.

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

Plant parts

Preparations

Effect types

Target tissues

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

Substance	Plant part	Preparation	Concentration	Analytical method	Source
Triterpene saponins	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI
Triterpene saponins	Leaves	Solvent extraction	—	Nuclear Magnetic Resonance (NMR)	Resolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

Effect	Target tissue	Plant part	Preparation	Test organism	Test type	Source
Digestive	Digestive: pancreas	Leaves	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive: pancreas	Leaves	Solvent extraction	—	In vitro	Resolve DOI
Digestive	Digestive: pancreas	Leaves	Solvent extraction	—	In vitro	Resolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

Tan Phat Nguyen., Thi Thao Vy Tran., Dinh Tri Mai., Tien Dung Le., Nhat Minh Phan., Trong Dat Bui. New C-20-gibberellin diterpene from the leaves of Schefflera sessiliflora De P. V. . Natural product research, 2015, vol. 29, no. 15, p. 1432-1436. DOI
Tan Phat Nguyen., Tien Dung Le., Nhat Minh Phan., Trong Dat Bui., Dinh Tri Mai. Triterpene saponins with alpha-glucosidase inhibition and cytotoxic activity from the leaves of Schefflera sessiliflora . Journal of asian natural products research, 2016, vol. 18, no. 6, p. 542-549. DOI
Nguyen Tan Phat., Le Thi Viet Hoa., Mai Dinh Tri., Le Tien Dung., Phan Nhat Minh., Bui Trong Dat. Two new oleanane-type triterpene saponins from the leaves of Schefflera sessiliflora De PV . Phytochemistry letters, 2015, vol. 11, p. 102-105. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue

Independent literature